• Soumitra Mandal

Gold nanoparticles (AuNPs) have emerged as a revolutionary innovation in the field of nanomedicine, showcasing unparalleled potential in advancing targeted cancer therapies. Their distinctive physicochemical properties, including high surface area-to-volume ratio, optical tunability due to surface plasmon resonance (SPR), and remarkable biocompatibility, render them exceptionally suited for multifaceted applications such as drug delivery, photothermal therapy (PTT), and enhanced imaging techniques. This review delves into the recent advancements in AuNPs' roles within cancer treatment, emphasizing key aspects like their versatile synthesis methods, strategic functionalization techniques for targeted action, intricate mechanisms of therapeutic efficacy, and the multifaceted challenges they face in achieving clinical application. The convergence of AuNPs with cutting-edge personalized medicine approaches heralds a new therapeutic frontier, poised to significantly elevate the effectiveness and specificity of cancer treatment paradigms while minimizing systemic side effects.

Gold Nanoparticles, Targeted Cancer Therapy, Nanomedicine, Photothermal Therapy, Drug Delivery Systems.

"Harnessing The Potential Of Gold Nanoparticles For Targeted Cancer Treatment: A Therapeutic Frontier", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 12, page no.g290-g296, December-2024, Available :http://www.jetir.org/papers/JETIR2412632.pdf

"Harnessing The Potential Of Gold Nanoparticles For Targeted Cancer Treatment: A Therapeutic Frontier", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 12, page no. ppg290-g296, December-2024, Available at : http://www.jetir.org/papers/JETIR2412632.pdf